CompanyDrug

J&J’s Rybrevant Secures Full FDA Approval for NSCLC with EGFR Exon 20 Insertions

CompanyDrug

Astellas Launches Late-Stage Trial in Japan for Nonhormonal Menopause Treatment

Policy / Regulatory

Hebei Province Proposes Measures for ‘Internet+’ Medical Services and Insurance Management

Company

Maruho Expands into China with New Wholly Owned Subsidiary in Beijing

CompanyDrug

Sino-US Laekna’s LAE102 Clinical Trial Filing Accepted for Review in Obesity and Metabolic Disorders

CompanyDeals

Haihe Pharmaceuticals Licenses Glumetinib to Taiho for Exclusive Development in Japan and Asia

CompanyDeals

CANbridge Pharmaceuticals Partners with Peking Union Medical College to Advance Rare Disease Research

CompanyDrug

Fosun Pharmaceutical Secures NMPA Approval for Phase II Study of FCN-338 and FCN-647 in Chronic Lymphocytic Leukemia

CompanyDrug

Shanghai Pharmaceuticals’ MediTrust Health Teams Up with Eisai to Enhance Alzheimer’s Prevention and Treatment

CompanyDrug

Fosun Pharmaceutical’s HanDaYuan Seeks NMPA Approval for Expanded Indications in Autoimmune Treatments

Policy / Regulatory

CDE Streamlines Patent Dispute Resolution for Generic Drug Filings with New Online Submission Process

CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for HRS-1167 Clinical Trials in Advanced Solid Tumors